1. Home
  2. FIBK vs HAE Comparison

FIBK vs HAE Comparison

Compare FIBK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Interstate BancSystem Inc. (DE)

FIBK

First Interstate BancSystem Inc. (DE)

HOLD

Current Price

$38.45

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$84.81

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIBK
HAE
Founded
1879
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
FIBK
HAE
Price
$38.45
$84.81
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$35.63
$84.13
AVG Volume (30 Days)
1.2M
605.4K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
5.46%
N/A
EPS Growth
34.25
N/A
EPS
0.61
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.91
$5.23
P/E Ratio
$61.89
$41.67
Revenue Growth
N/A
N/A
52 Week Low
$27.60
$47.32
52 Week High
$40.60
$87.32

Technical Indicators

Market Signals
Indicator
FIBK
HAE
Relative Strength Index (RSI) 46.27 75.48
Support Level $35.49 $78.87
Resistance Level $37.82 $86.72
Average True Range (ATR) 0.80 2.40
MACD -0.26 0.49
Stochastic Oscillator 6.86 97.68

Price Performance

Historical Comparison
FIBK
HAE

About FIBK First Interstate BancSystem Inc. (DE)

First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: